London, Ont. Researchers Find Genetic Testing Can Unlock New Cancer Treatment Options
ASCO recommends broad biomarker testing for non-small cell lung cancer, including tissue or blood panels, to guide targeted treatment choices.
4 Articles
4 Articles
Could one test change your lung cancer treatment? Understanding molecular profiling
Molecular profiling looks for genetic changes driving a lung tumour and can help doctors match treatment to the cancer's biology. Here's how the test works, who may benefit from it and why testing before treatment can matter.
London, Ont. researchers find genetic testing can unlock new cancer treatment options
A new study from London Health Sciences Centre Research Institute (LHSCRI) is pointing to a potential shift in how doctors treat cancer, finding that expanded genetic testing can help identify treatment options that may otherwise be missed.
Advanced genetic testing opens new treatment options for nearly one in three cancer patients, study finds
A new study from London Health Sciences Centre Research Institute (LHSCRI) shows that expanded genetic testing can help match cancer patients with more personalized treatment options, with nearly one in three found eligible for therapies not typically used for their specific type of cancer based on the unique DNA of their tumor.
Study Finds Broader Genetic Testing Could Transform Cancer Treatment
Drs. Sadikovic (left) and Welch (right) A new study from London Health Sciences Centre Research Institute (LHSCRI) shows that expanded genetic testing can help match cancer patients to more personalized treatment options, with nearly one in three found to be eligible for therapies not typically used for their specific type of cancer based on the unique DNA of their tumour. When someone is diagnosed with cancer, physicians run tests to learn more…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium







